-
First of its kind cancer stem cell research unlocks clues to treatment resistance
firstwordpharma
January 22, 2017
Study data published in the journal Oncotarget suggest that a molecule lost from cancer stem cells, called miR-17, is important in driving oesophageal tumour resistance to radiotherapy, ScienceDaily reported.
-
Verastem Announces Executive Leadership Appointments and Changes
americanpharmaceuticalreview
January 22, 2017
Verastem, Inc., focused on discovering and developing drugs to treat cancer, announced that Hagop Youssoufian, MSc, MD, has been appointed Head of Hematology and Oncology Development.
-
Merck in $230 million swoop for Vertex cancer programmes
pharmafile
January 17, 2017
Merck has completed a deal with Boston-based biotech firm Vertex Pharmaceuticals for the rights to four cancer programmes worth $230 million.
-
Study reveals yoga may help children with cancer
worldpharmanews
January 13, 2017
Quality of life of patients doing yoga improved, according to the conclusions of "Results of a Pilot Yoga Intervention to Improve Pediatric Cancer Patients' Quality of Life and Physical Activity and Parents' Well-being".
-
Bavarian Nordic sees 'huge potential' in cancer vaccine combos, CEO says
fiercepharma
January 11, 2017
As interest in cancer vaccine combos surges, Bavarian Nordic is inclined to remain an independent vaccine company, according to CEO Paul Chaplin.